70 studies found for:    Narcolepsy
Show Display Options
Rank Status Study
1 Completed A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: JNJ-17216498;   Drug: Modafinil
2 Completed PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Narcolepsy;   Sleep Apnea, Obstructive
Intervention: Drug: Modafinil
3 Completed Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.
Condition: Treatment of Excessive Daytime Sleepiness in Narcolepsy.
Interventions: Drug: BF2.649;   Drug: Vigil;   Drug: palcebo
4 Completed
Has Results
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
Condition: Narcolepsy
Interventions: Drug: Xyrem;   Drug: Xyrem Placebo;   Drug: Modafinil at established dose;   Drug: Modafinil (Placebo)
5 Completed Body Weight Regulation in Patients With Narcolepsy
Condition: Narcolepsy
Intervention:
6 Completed Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Modafinil
7 Completed
Has Results
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: ADX-N05;   Drug: Placebo
8 Completed
Has Results
A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy
Conditions: Excessive Daytime Sleepiness;   Narcolepsy
Interventions: Drug: Placebo;   Drug: PF-03654746
9 Completed
Has Results
Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: Armodafinil;   Drug: Placebo
10 Unknown  Risk of Narcolepsy Associated With Administration of H1N1 Vaccine
Condition: Narcolepsy
Intervention: Other: No intervention
11 Terminated Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: GSK189254
12 Recruiting Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Armodafinil
13 Completed
Has Results
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Conditions: Narcolepsy;   Sleep Apnea, Obstructive;   Sleep Apnea Syndromes;   Shift-Work Sleep Disorder
Intervention: Drug: CEP-10953 (Armodafinil)
14 Completed
Has Results
Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness
Conditions: Excessive Daytime Sleepiness;   Narcolepsy;   Obstructive Sleep Apnea/Hypopnea Syndrome;   Chronic Shift Work Sleep Disorder
Intervention: Drug: Armodafinil 100 to 250 mg/day
15 Completed
Has Results
Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Xyrem (sodium oxybate) oral solution
16 Completed Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy
Conditions: Narcolepsy;   Excessive Daytime Sleepiness;   Cataplexy;   Sleep Disorders
Interventions: Drug: BF2.649;   Drug: Modafinil;   Drug: Placebo
17 Active, not recruiting Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)
Conditions: Narcolepsy;   Cataplexy
Intervention: Drug: BF2.649
18 Completed Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients
Condition: Narcolepsy
Intervention: Drug: sodium oxybate
19 Completed A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness
Condition: Narcolepsy
Interventions: Drug: ADX-N05;   Drug: Placebo
20 Not yet recruiting A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Xyrem

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years